Recurrent Respiratory PapillomatosisSymptoms, Doctors, Treatments, Advances & More
Recurrent Respiratory Papillomatosis Overview
Learn About Recurrent Respiratory Papillomatosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Emory Clinic Urology At Midtown
Adam Klein is an Otolaryngologist practicing medicine in Atlanta, Georgia. Dr. Klein is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Laryngitis, Laryngectomy, and Tissue Biopsy.
Massachusetts General Hospital
Sara Pai is a General Surgeon practicing medicine in Boston, Massachusetts. Dr. Pai is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Recurrent Respiratory Papillomatosis, Head and Neck Squamous Cell Carcinoma (HNSCC), Human Papillomavirus Infection, Adenoid Cystic Carcinoma, and Thyroidectomy.
Yang Xiao practices practicing medicine in Beijing, China. Mr. Xiao is rated as an Elite expert by MediFind in the treatment of Recurrent Respiratory Papillomatosis. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Recurrent Respiratory Papillomatosis, Perichondritis, Throat Cancer, and Laryngeal Cancer.
Summary: This research study is studying Lenvatinib in combination with Pembrolizumab in people with human papillomavirus (HPV)-associated recurrent respiratory papillomatosis (RRP). The names of the study drugs involved in this study are: * Pembrolizumab * Lenvatinib
Summary: The purpose of this study is to evaluate the safety and immunogenicity of autologous DC vaccine in recurrent respiratory papillomatosis patients